1 / 15

Within the same individual

VARIATION IN DRUG RESONSIVNESS. Decrease in drug effects. Development of side effects. Between different individuals. Within the same individual. ilo s. By the end of this lecture you will be able to : .

vine
Download Presentation

Within the same individual

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. VARIATION IN DRUG RESONSIVNESS Decrease in drug effects. Development of side effects Between different individuals Within the same individual

  2. ilos By the end of this lecture you will be able to : • Distinguish difference between tolerance and desensitization ( tachyphylaxis ) and reasons for their development • Recognize patterns of adverse drug reactions (ADR) TOLERANCE / DESENSITIZATION & ADVERSE DRUG REACTIONS

  3. Phenomenon of variation in drug response, where by there is a gradual diminution of the response to the drug when given continuously or repeatedly TOLERANCE and DESENSITIZATION

  4. DIMINUTION OF A RESPONSE Rapid, in the course of few minutes Gradual in the course of few days to weeks TACHYPHYLAXIS / DESENSITIZATION TOLERANCE These SHOULD BE DISTINGUISHED FROM Loss of effectiveness of antimicrobial agent Resistance

  5. REASONS FOR DEVELOPMENT OF TOLERANCE ↓ drug availability at the relevant receptors due to pharmaco- kinetic variables Nullification of drug response by a physiological adaptative homeostatic response PRE RECEPTOR EVENTS EVENTS AT RECEPTORS POST RECEPTOR EVENTS Drug becomes: > metabolized or excreted < absorbed altered distribution to tissues Antihypertensive effects of ACE Is become nullified by activation of reninangiotensin system by NSAIDs eg. Barbiturates  metabolism of Contraceptive pills = it availability LOSS OF THERAPEUTIC EFFICACY Refractoriness

  6. REASONS FOR DEVELOPMENT OF TOLERANCE PRE RECEPTOR EVENTS EVENTS AT RECEPTORS POST RECEPTOR EVENTS EXHUSTION OF MEDIATORS BINDING ALTERATION ↓ number of receptors. Isoprenaline activation to b receptors →↑ R recycling by endocytosis [structural defect] Depletion of mediator stores by amphetamine Phosphorylation of R i.e. ß-adrenoceptors→↓ activation of AC to related ionic channel [functional defect] DOWN REGULATION DOWN REGULATION BINDING ALTERATION

  7. DOWN REGULATION

  8. ADVERSE DRUG REACTIONS [ADR] • Harmful or seriously unpleasant effects occurring at doses intended for therapeutic effects.

  9. TYPES OF ADR Type A Type C Type E Augmented Continuous End-of-Use PREDICTABLE Occurs during chronic drug administration Occurs by sudden stop- page of chronic drug use due to existing adaptive changes Occurs consequent but in excess of drug primary pharmacological effect. Of quantitative nature Osteoporosis  chronic corticosteroidintake .. Withdrawal syndrome Morphine Hemorrhage Warfarin Type D Type B Delayed Occurs after long period of time even after drug stoppage Bizzar UNPREDICTABLE • TERATOGENICITYRetinoids • CARCINOGENICITY tobacoo smoking Occurs different [heterogenous / idiosyncrotic] to known drug pharmacological effect. Usually due to patient’s genetic defect or immunological response. Of qualitative nature Thrombocytopenia Quinine

  10. Comparison between typeA & B ADRs

  11. Examples of TYPE A & B ADR DrugType A Type B Chlorpromazine Sedation Cholestatic jaundice Naproxen GIT haemorrhage Agranulocytosis Phenytoin Ataxia Hepatitis, lymphadenopathy Thiazides Hypokalaemia Thrombocytopenia Quinine Tinnitus Thrombocytopenia Warfarin Bleeding Breast necrosis Genetics Variation / defect Immunological Predisposition

  12. TYPE B Immunological Predisposition IgE The drug or its bi-product [protein macromolecules or haptens] react as antigens and provoke immune response that results in damage to the tissue Hypersensitivity Reaction IgG 1st exposure to a drug Sensitization T killer cells Repeated exposures HYPERSENSITIVITY REACTION

  13. TYPE B If due to immunological response 1st exposure to a drug Repeated exposures HYPERSENSITIVITY REACTION Sensitization TYPE I Anaphylaxsis TYPE II Cytotoxic TYPE III Immune complex TYPE IV Cell mediated Release of mediators from mast cells or blood basophils Antibody-directed cell-mediated lysis Deposition of soluble antigen–antibody- complement complexes in small blood vessels Interaction release cytokines that attracts inflammatory cell infiltrate Urticaria rhinitis, bronchial asthma by Penicillin, Haemolyticanaemia thrombocytopenia by Quinidine Serum sickness (fever arthritis enlarged lymph nodes, urticaria) by Sulphonamides, Contact dermatitis by local anaestheticscreams

  14. TYPE B TYPE I TYPE II TYPE III TYPE IV Release of histamine, serotonin leukotrienes from tissue mast cells or blood basophils Antibody-directed cell-mediated lysis Deposition of soluble antigen–antibody- complement complexes in small blood vessels Interaction release cytokines that attracts inflammatory cell infiltrate Contact dermatitis by local anaesthetics creams , anti histamine creams, topical antibiotics Haemolytic anaemia thrombocytopenia by Penicillin, Quinidine Urticaria rhinitis, bronchial asthma by Penicillin, Streptomycin Serum sickness (fever arthritis enlarged lymph nodes, urticaria) by Sulphonamides, Penicillin, Streptomycin

  15. G O O D L U C K G O O D L U C K TOLERANCE / DESENSITIZATION & ADVERSE DRUG REACTIONS

More Related